aap acquires rights on Adcon® from Wright Medical Technologies

aap Implantate AG, a leading European Bio-Implants company acquires WMT´s products to inhibit post-surgical scarring and adhesions following lumbar surgery named Adcon® L with immediate effect. Included are all intellectual property, name and distribution rights.

aap´s Dutch subsidiary EMCM acted based on its innovative Hydrogel technology as producer of Adcon® L already before signing the agreement. Together with this product, successfully launched in a lot of countries already, aap takes over an established network of international distribution partners.

aap intends to achieve an FDA registration and to develop under the brand Adcon® a broader product portfolio in the sector of adhesion control (prevention of organic tissue adhesion) within the coming years.

For 2008 aap expects a revenue with Adcon® products of approx. EUR 1.5 million and a positive contribution margin to its results.